1401PAn Australian multi-centre experience of the use of peptide receptor radionuclide therapy for bronchial carcinoid tumours

Abstract Background Peptide receptor radionuclide therapy (PRRT) is an established treatment modality for advanced midgut neuroendocrine tumours (NET) (1), based on the presence of somatostatin receptors (SSTR). This therapy should be effective for SSTR expressing NETs from all sites of origin. SSTR...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of oncology 2019-10, Vol.30 (Supplement_5)
Hauptverfasser:	Lim, L E, Chan, D L, Thomas, D, Wyld, D K, Cehic, G, Macdonald, W, Du, Y T, Tincknell, G, Kuchel, A, Pavlakis, N, Bailey, D, Davis, A, Segelov, E
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!